Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
microRNA 6886 (MIR6886) is a human microRNA gene producing a small, single-stranded, non-coding RNA molecule of ~22 nucleotides. Like other microRNAs, it is transcribed as a primary transcript from genomic DNA, processed into mature miRNA by Drosha/Dicer complexes, and functions primarily by binding to complementary seed sequences on target mRNAs. This binding leads to either degradation or translational inhibition of the mRNA, resulting in gene silencing. MIR6886 has been studied in system-wide comparisons and has been found to participate in regulation of gene sets involved in key signaling pathways such as the MAPK cascade, which is relevant in cancer biology. The biological and clinical relevance of individual miRNAs like MIR6886 continue to be investigated, but its classification as a microRNA indicates a general role in gene regulation and potential involvement as a therapeutic target or biomarker in disease.
Gene silencing via seed sequence binding to 3' UTR of target mRNAs, resulting in degradation or inhibition of translation
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on microRNA 6886 (MIR6886).